Skip to main content
Top
Published in: Rheumatology International 8/2005

01-10-2005 | Original Article

Association of CYP17 gene polymorphism and rheumatoid arthritis in Chinese patients in central Taiwan

Authors: Sui-Foon Lo, Chung-Ming Huang, Hsiu-Chen Lin, Chang-Hai Tsai, Fuu-Jen Tsai

Published in: Rheumatology International | Issue 8/2005

Login to get access

Abstract

We investigated whether there is an association between polymorphism of the CYP17 gene and rheumatoid arthritis in Chinese patients in central Taiwan. Genomic DNA was extracted from the peripheral blood of 146 female and 47 male RA patients, as well as from 42 female and 59 male control subjects; restriction fragment length polymorphism (defined as the A1 and A2 alleles) was then determined. Clinical variables such as rheumatoid factor positivity, extra-articular manifestations, and joint erosion were also investigated for the RA patients. We found that more male RA patients had the A1 allele (P=0.019) and fewer female RA patients the A2 allele than control subjects (P=0.048). In male RA patients, A1 carriers showed more extra-articular manifestations (P=0.048). In female patients, a significant decrease in A2 carriers mainly occurred in the later-onset age group (P=0.024). This study suggests that the A2 allele may significantly decrease the overall risk of developing RA. In women, the protective effect of A2 mainly affects the older age group. In men, the clinical severity of RA may decrease in patients with the A2/A2 genotype.
Literature
1.
go back to reference Masi AT (1995) Sex hormones and rheumatoid arthritis: cause and effect relationship in a complex pathophysiology? Clin Exp Rheumatol 13:227–240PubMed Masi AT (1995) Sex hormones and rheumatoid arthritis: cause and effect relationship in a complex pathophysiology? Clin Exp Rheumatol 13:227–240PubMed
2.
go back to reference Cutolo M, Accardo S (1991) Sex hormones, HLA and rheumatoid arthritis. Clin Exp Rheumatol 9:641–646PubMed Cutolo M, Accardo S (1991) Sex hormones, HLA and rheumatoid arthritis. Clin Exp Rheumatol 9:641–646PubMed
3.
go back to reference Cutolo M, Masi AT (1998) Do androgens influence the pathophysiology of rheumatoid arthritis? Facts and hypothesis. J Rheumatol 25:1041–1047PubMed Cutolo M, Masi AT (1998) Do androgens influence the pathophysiology of rheumatoid arthritis? Facts and hypothesis. J Rheumatol 25:1041–1047PubMed
4.
go back to reference Cutolo M (1997) Do sex hormones modulate the synovial macrophages in rheumatoid arthritis? Ann Rheum Dis 56:281–286PubMed Cutolo M (1997) Do sex hormones modulate the synovial macrophages in rheumatoid arthritis? Ann Rheum Dis 56:281–286PubMed
5.
go back to reference Sthoeger ZM, Chiorazzi N, Lahita RG (1988) Regulation of the immune response by sex steroids. J Immunol 141:91–98PubMed Sthoeger ZM, Chiorazzi N, Lahita RG (1988) Regulation of the immune response by sex steroids. J Immunol 141:91–98PubMed
6.
go back to reference Novotny EA, Raveche ES, Sharrow S, Ottinger M, Steinberg AD (1983) Analysis of thymocyte subpopulations following treatment with sex hormones. Clin Immunol Immunopathol 25:205–217CrossRef Novotny EA, Raveche ES, Sharrow S, Ottinger M, Steinberg AD (1983) Analysis of thymocyte subpopulations following treatment with sex hormones. Clin Immunol Immunopathol 25:205–217CrossRef
7.
go back to reference Grossman CJ (1985) Interaction between the gonadal steroids and the immune system. Science 227:257–261PubMed Grossman CJ (1985) Interaction between the gonadal steroids and the immune system. Science 227:257–261PubMed
8.
go back to reference Cutolo M, Balleari E, Giusti M, Monachesi M, Accardo S (1988) Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. Arthritis Rheum 31:1314–1317PubMed Cutolo M, Balleari E, Giusti M, Monachesi M, Accardo S (1988) Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. Arthritis Rheum 31:1314–1317PubMed
9.
go back to reference Junghers P, Nahoul K, Pelissier C, Dougados M, Tron F, Bach JF (1982) Low plasma androgens in women with active or quiescent systemic lupus erythematosus. Arthritis Rheum 25:454–457PubMed Junghers P, Nahoul K, Pelissier C, Dougados M, Tron F, Bach JF (1982) Low plasma androgens in women with active or quiescent systemic lupus erythematosus. Arthritis Rheum 25:454–457PubMed
10.
go back to reference Lahita RG, Bradlow HL, Kunkel HG, Fishman J (1981) Increased 16-alpha-hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab 53:174–178PubMed Lahita RG, Bradlow HL, Kunkel HG, Fishman J (1981) Increased 16-alpha-hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab 53:174–178PubMed
11.
go back to reference Masi AT, Josipovic DB, Jefferson WE (1984) Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): gas-liquid chromatographic (GLC) studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion. Semin Arthritis Rheum 14:1–23CrossRefPubMed Masi AT, Josipovic DB, Jefferson WE (1984) Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): gas-liquid chromatographic (GLC) studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion. Semin Arthritis Rheum 14:1–23CrossRefPubMed
12.
go back to reference Lahita RG, Kunkel HG, Bradlow HL (1983) Increased oxidation of testosterone in systemic lupus erythematosus. Arthritis Rheum 26:1517–1521PubMed Lahita RG, Kunkel HG, Bradlow HL (1983) Increased oxidation of testosterone in systemic lupus erythematosus. Arthritis Rheum 26:1517–1521PubMed
13.
go back to reference Brentano ST, Picardo-Leonard J, Mellon SH, Moore CCD, Miller WL (1990) Tissue-specific, cyclic adenosine 3’, 5’-monophosphate-induced and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells. Mol Endocrinol 4:1972–1979PubMed Brentano ST, Picardo-Leonard J, Mellon SH, Moore CCD, Miller WL (1990) Tissue-specific, cyclic adenosine 3’, 5’-monophosphate-induced and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells. Mol Endocrinol 4:1972–1979PubMed
14.
go back to reference Cutolo M, Villaggio B, Sulli A, Seriolo B, Giusti M (2000) CYP17 polymorphisms and androgen levels in postmenopausal patients with rheumatoid arthritis. Clin Exp Rheumatol 18:420–421PubMed Cutolo M, Villaggio B, Sulli A, Seriolo B, Giusti M (2000) CYP17 polymorphisms and androgen levels in postmenopausal patients with rheumatoid arthritis. Clin Exp Rheumatol 18:420–421PubMed
15.
go back to reference Picado-Leonard J, Miller WL (1987) Cloning and sequence of the human gene for P450c17 (steroid 17α-hydroxylase/17, 20 lyase): similarity with the gene for P450c21. DNA 6:439–448PubMed Picado-Leonard J, Miller WL (1987) Cloning and sequence of the human gene for P450c17 (steroid 17α-hydroxylase/17, 20 lyase): similarity with the gene for P450c21. DNA 6:439–448PubMed
16.
go back to reference Carey AH, Waterworth D, Patel K, White D, Little J, Novelli P, Frank S, Williamson R (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3:1873–1876PubMed Carey AH, Waterworth D, Patel K, White D, Little J, Novelli P, Frank S, Williamson R (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 3:1873–1876PubMed
17.
go back to reference Feigelson HS, Coetzee, GA, Kolone LN, Ross RK, Henderson BE (1997) A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 57:1063–1065PubMed Feigelson HS, Coetzee, GA, Kolone LN, Ross RK, Henderson BE (1997) A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 57:1063–1065PubMed
18.
go back to reference Bergman-Jungestrom M, Gentile M, Lundin AC, Wingren S (1999) Association between CYP17 gene polymorphism and risk of breast cancer in young women. Int J Cancer 84:350–353CrossRefPubMed Bergman-Jungestrom M, Gentile M, Lundin AC, Wingren S (1999) Association between CYP17 gene polymorphism and risk of breast cancer in young women. Int J Cancer 84:350–353CrossRefPubMed
19.
go back to reference Young IE, Kurian KM, Annink C, Kunkler IH, Anderson VA, Cohen BB, Hooper ML, Wyllie AH, Steel CM (1999) A polymorphism in the CYP17 gene is associated with male breast cancer. Br J Cancer 81:141–143CrossRefPubMed Young IE, Kurian KM, Annink C, Kunkler IH, Anderson VA, Cohen BB, Hooper ML, Wyllie AH, Steel CM (1999) A polymorphism in the CYP17 gene is associated with male breast cancer. Br J Cancer 81:141–143CrossRefPubMed
20.
go back to reference Diamanti-Kandarakis E, Bartzis MI, Zapanti ED, Spina GG, Filandra FA, Tsianateli TC, Bergiele AT, Kouli CR (1999) Polymorphism T–>C (–34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome. Fertil Steril 71:431–435CrossRefPubMed Diamanti-Kandarakis E, Bartzis MI, Zapanti ED, Spina GG, Filandra FA, Tsianateli TC, Bergiele AT, Kouli CR (1999) Polymorphism T–>C (–34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome. Fertil Steril 71:431–435CrossRefPubMed
21.
go back to reference Lunn RM, Bell DA, Mohler JL, Taylor JA (1999) Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2) Carcinogenesis (Oxford) 20:1727–1731 Lunn RM, Bell DA, Mohler JL, Taylor JA (1999) Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2) Carcinogenesis (Oxford) 20:1727–1731
22.
go back to reference Gsur A, Bernhofer G, Hinteregger S, Haidinger G, Schatzl G, Madersbacher S, Marberger M, Vutuc C, Micksche MA (2000) Polymorphism in the CYP17 gene is associated with prostate cancer risk. Int J Cancer 87:434–437CrossRefPubMed Gsur A, Bernhofer G, Hinteregger S, Haidinger G, Schatzl G, Madersbacher S, Marberger M, Vutuc C, Micksche MA (2000) Polymorphism in the CYP17 gene is associated with prostate cancer risk. Int J Cancer 87:434–437CrossRefPubMed
23.
go back to reference Huang J, Ushiyama T, Inoue K, Mori K, Hukuda S (1999) Possible association of CYP17 gene polymorphisms with the onset of rheumatoid arthritis. Clin Exp Rheumatol 17:721–724PubMed Huang J, Ushiyama T, Inoue K, Mori K, Hukuda S (1999) Possible association of CYP17 gene polymorphisms with the onset of rheumatoid arthritis. Clin Exp Rheumatol 17:721–724PubMed
24.
go back to reference Sullivan KE, Mannery T, Petri MA (1998) The polymorphic CYP17 allele is not found with increased frequency in systemic lupus erythematosus. Arthritis Rheum 41:940–941CrossRefPubMed Sullivan KE, Mannery T, Petri MA (1998) The polymorphic CYP17 allele is not found with increased frequency in systemic lupus erythematosus. Arthritis Rheum 41:940–941CrossRefPubMed
25.
go back to reference Yen JH, Chen JR, Tsai WJ, Tsai JJ, Liu HW (1995) HLA-DRB1 genotyping in patients with rheumatoid arthritis in Taiwan. J Rheumatol 22:1450–1454PubMed Yen JH, Chen JR, Tsai WJ, Tsai JJ, Liu HW (1995) HLA-DRB1 genotyping in patients with rheumatoid arthritis in Taiwan. J Rheumatol 22:1450–1454PubMed
26.
go back to reference Wadelius M, Andersson AO, Johansson JE, Wadelius C, Rane E (1999) Prostate cancer associated with CYP17genotype. Pharmacogenetics 9:635–639PubMed Wadelius M, Andersson AO, Johansson JE, Wadelius C, Rane E (1999) Prostate cancer associated with CYP17genotype. Pharmacogenetics 9:635–639PubMed
27.
go back to reference Habuchi T, Liging Z, Suzuki T, Sasaki R, Tsuchiya N, Tachiki H, Shimoda N, Satoh S, Sato K, Kakehi Y, Kamoto T, Ogawa O, Kato T (2000) Increased risk of prostate cancer and benign prostatic hyperplasia associated with CYP17 gene polymorphism with a gene dosage effect. Cancer Res 60:5710–5713PubMed Habuchi T, Liging Z, Suzuki T, Sasaki R, Tsuchiya N, Tachiki H, Shimoda N, Satoh S, Sato K, Kakehi Y, Kamoto T, Ogawa O, Kato T (2000) Increased risk of prostate cancer and benign prostatic hyperplasia associated with CYP17 gene polymorphism with a gene dosage effect. Cancer Res 60:5710–5713PubMed
28.
go back to reference Cutolo M, Sulli A, Seriolo B, Accardo S, Masi AT (1995) Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 13:217–226PubMed Cutolo M, Sulli A, Seriolo B, Accardo S, Masi AT (1995) Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 13:217–226PubMed
29.
go back to reference Haiman CA, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Speizer FE, Kelsey KT, Hunter DJ (1999) The relationship between polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 59:1015–1020PubMed Haiman CA, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Speizer FE, Kelsey KT, Hunter DJ (1999) The relationship between polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 59:1015–1020PubMed
Metadata
Title
Association of CYP17 gene polymorphism and rheumatoid arthritis in Chinese patients in central Taiwan
Authors
Sui-Foon Lo
Chung-Ming Huang
Hsiu-Chen Lin
Chang-Hai Tsai
Fuu-Jen Tsai
Publication date
01-10-2005
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 8/2005
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-004-0479-4

Other articles of this Issue 8/2005

Rheumatology International 8/2005 Go to the issue